Evidence map›Paper›PMID 32271902›Full record

ArticleBlood advances2020

Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing.

Samantha L Smith, Philippa R Kennedy, Kevin B Stacey, Jonathan D Worboys, Annie Yarwood, Seungmae Seo, Everardo Hegewisch Solloa, Brandon Mistretta, Sujash S Chatterjee, Preethi Gunaratne and 10 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it, 214 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Priming of Multiple HIV Neutralizing B Cell Precursors in Humans.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Samantha L SmithThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Philippa R KennedyThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Kevin B StaceyThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Jonathan D WorboysThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Annie YarwoodCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
Seungmae SeoDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
Everardo Hegewisch SolloaDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
Brandon MistrettaDepartment of Biochemistry, University of Houston, Houston, TX; and.
Sujash S ChatterjeeDepartment of Biochemistry, University of Houston, Houston, TX; and.
Preethi GunaratneDepartment of Biochemistry, University of Houston, Houston, TX; and.
Kimaada AlletteDepartment of Genetics and Genomic Sciences, and.
Ying-Chih WangDepartment of Genetics and Genomic Sciences, and.
Melissa Laird SmithDepartment of Genetics and Genomic Sciences, and.
Robert SebraDepartment of Genetics and Genomic Sciences, and.
Emily M MaceDepartment of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
Amir HorowitzDepartment of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Wendy ThomsonCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
Paul MartinThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Steve EyreCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
Daniel M DavisThe Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, and.
Manchester Academic Health Science Centre · GBInstitute of Immunology · HRPediatrics and Genetics · USColumbia University · USUniversity of Houston · USTisch Hospital · US

Funding

Harnessing NK cell effector function for immunotherapiesR21AI130760 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOROWITZ, AMIR · 2017 to 2018
$466k
Medical Research Council MC_PC_15072NIAID NIH HHS R21 AI130760Versus Arthritis 20385Versus Arthritis 21745Wellcome Trust 110091Wellcome Trust 202865/Z/16/Z
6 · The paper itself

Abstract

Human natural killer (NK) cells in peripheral blood perform many functions, and classification of specific subsets has been a longstanding goal. We report single-cell RNA sequencing of NK cells, comparing gene expression in unstimulated and interleukin (IL)-2-activated cells from healthy cytomegalovirus (CMV)-negative donors. Three NK cell subsets resembled well-described populations; CD56brightCD16-, CD56dimCD16+CD57-, and CD56dimCD16+CD57+. CD56dimCD16+CD57- cells subdivided to include a population with higher chemokine mRNA and increased frequency of killer-cell immunoglobulin-like receptor expression. Three novel human blood NK cell populations were identified: a population of type I interferon-responding NK cells that were CD56neg; a population exhibiting a cytokine-induced memory-like phenotype, including increased granzyme B mRNA in response to IL-2; and finally, a small population, with low ribosomal expression, downregulation of oxidative phosphorylation, and high levels of immediate early response genes indicative of cellular activation. Analysis of CMV+ donors established that CMV altered the proportion of NK cells in each subset, especially an increase in adaptive NK cells, as well as gene regulation within each subset. Together, these data establish an unexpected diversity in blood NK cells and provide a new framework for analyzing NK cell responses in health and disease.

Indexed as

CytomegalovirusCytomegalovirus InfectionsHumansKiller Cells, NaturalReceptors, KIRSequence Analysis, RNAReceptors, KIR

Identifiers

PMID32271902
PMCPMC7160259
OpenAlexW3009874104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.